Discover why 23andMe is the best DNA test for people with African ancestry
23andMe offers the most detailed view of African ancestry, connecting you to hundreds of ethnic groups in Africa, plus ancient maternal and paternal lineages. You can also get personalized health insights, all with full control over your data.

Most comprehensive ancestry detail
23andMe offers the most comprehensive African ancestry detail of any DNA testing company, connecting users to over 260 African ethnic groups, including Yoruba, Igbo, Kongo, and Zulu peoples, plus more than 200 groups in the African diaspora like the Gullah and Garifuna.
Trace ancient African lineages
With haplogroups, you can see where your ancient maternal and paternal lineages originated long ago and learn about the people and places they connect you to. Via analysis of mitochondrial and Y-chromosome DNA.
Optional health reports including Sickle Cell
Access 110+ health reports, including reports on conditions that disproportionately affect people with African ancestry such as sickle cell anemia, high blood pressure, preeclampsia, prostate cancer, type 2 diabetes, and more.
Ancestry reports and features
23andMe, now a research non-profit, has the largest community of research participants with African ancestry in the world, and we have been committed to increasing representation in our cohort through efforts like and more. That focus on diversity has unlocked key discoveries through research and enabled our team to provide more ancestry detail in Africa than any other DNA testing company.
Real stories from real customers
Industry-leading DNA test with FDA cleared HEALTH REPORTS
Learn more about our FDA authorizations →Health reports on conditions that disproportionately impact the Black/African American community
23andMe offers many reports about how your DNA may impact your health and wellness. This page highlights reports on conditions that disproportionately affect Black/African American individuals and people of African descent.


Note that our health reports have limitations
Our reports don't test for every possible genetic variant linked to each condition, due to limitations of our genotyping technology. Because some variants are more common in certain populations, we may miss variants relevant to your ancestry.
For reports powered by 23andMe research, like our Colorectal Cancer PRS report, we sometimes lack sufficient data to create a genetic prediction that meets our scientific standards for all ancestries. This means results may not be available for some people.
You are in control of your data
It's your data, so you call the shots. From the moment you register your kit and set up your private account, you have meaningful choice in everything you do. That means you decide how your information is used and whether it is shared. You are free to change your mind at any time. You can download your data, delete your account or have us discard your sample in your account settings at any point.
Learn more about our privacy and security practices →Advancing research equity and health outcomes
23andMe is proactively building a more diverse community of researchers and participants to improve research equity and health outcomes for Black/African Americans.
Community Impact Programs
Recent initiatives focused on health conditions that disproportionately impact the Black/African American community, in partnership with organizations rooted and engaged in the community.
Scientific Leaders
23andMe has the largest cohort of people with African ancestry who have consented to participate in genetic research in the world, and we prioritize diversity through efforts like the African Genetics Project, the Global Genetics Project, and more. That focus on diversity has unlocked key discoveries through research.
Publications
2014
The genetic ancestry of African Americans, Latinos, and European Americans across the United States
Study significance: This study was pivotal in enhancing understanding of the genetic makeup of major ethnic groups in the United States, revealing the ongoing influence of historical and social factors on genetic diversity.
Published in: The American Journal of Human Genetics
2020
Genetic Consequences of the Transatlantic Slave Trade in the Americas
Study significance: This study represents the most detailed genetic analysis of the genetic impact of the transatlantic slave trade on populations across the Americas. It used data from over 50,000 individuals from the 23andMe database, representing African, European, and Indigenous American ancestries, to trace the genetic legacy of the forced migration of millions of Africans to the Americas.
Published in: The American Journal of Human Genetics
2023
The genetic legacy of African Americans from Catoctin Furnace
Study significance: This study demonstrates that when studied responsibly with input from stakeholders, long-buried DNA can be used to uncover obfuscated or forgotten histories of marginalized individuals.
Published in: Science
2023
A new method for multi-ancestry polygenic prediction improves performance across diverse populations
Study significance: Enables better risk-prediction models for individuals of non-European ancestry.
Published in: Nature Genetics
2024
Ancestry-Independent Risk of Venous Thromboembolism in Individuals with Sickle Cell Trait vs. Factor V Leiden
Study significance: This is the largest study ever conducted on sickle cell.
Published in: Blood Advances
Frequently Asked Questions
Have questions about our DNA test for people with African ancestry? Find answers to common questions about our testing process, privacy protections, and what makes 23andMe unique.
Find the service that is right for you
Ancestry Service | 23andMe+ Premium Service | 23andMe+ Total Health | |
|---|---|---|---|
| Ancestry Reports and Features | |||
| Ancestry Reports Includes Ancestry Composition, Maternal & Paternal Haplogroups, Neanderthal Ancestry. With 12 broad African reference populations, 260+ African ethnic groups, and more than 200 African American genetic groups. | ✓ | ✓ | ✓ |
| DNA Relative Finder (opt in) Find and connect with relatives in the 23andMe database who share DNA with you. | ✓ | ✓ | ✓ |
| Automatic Family Tree Builder Start a family tree automatically based on your DNA. | ✓ | ✓ | ✓ |
| Enhanced ancestry features Get advanced filtering for DNA Relative Finder and access up to 5000 DNA relatives. | — | ✓ | ✓ |
| Historical MatchesSM Uncover your historical and ancient relatives, linking you to the past. Including historical and ancient individuals from West Africa, Southern Africa, and East Africa, as well as individuals of African descent who were enslaved at Catoctin Iron Furnace in Maryland. | — | ✓ | ✓ |
| Health Reports and Features | |||
| Health Predisposition Reports** Including: BRCA1/BRCA2 (Selected Variants), Late-Onset Alzheimer's Disease, Type 2 Diabetes (Powered by 23andMe Research) | — | 40+ Including some conditions that disproportionately impact Black and African American communities | 40+ Including some conditions that disproportionately impact Black and African American communities |
| Carrier Status Reports** Including conditions that disproportionately impact Black and African American communities, such as Sickle Cell Anemia and other blood disorders (hemoglobinopathies). | ✓ | ✓ | ✓ |
| Wellness Reports Including: Deep Sleep, Lactose Intolerance, Genetic Weight | — | 10+ | 10+ |
| Pharmacogenetics reports*** Discover how your DNA may impact how your body processes certain medications. | — | ✓ | ✓ |
| Exome Sequencing ReportsΔ Advanced DNA sequencing that looks at all the protein-coding regions of the genome. | — | — | ✓ |
| Blood Testing Eligible participants may order in-person blood testing initiated by a clinician. | Add-on purchase | Add-on purchase | ✓ 2x/yr included |
| Other | |||
| Trait Reports 30+ traits including: Sweet vs. Salty, Unibrow | ✓ | ✓ | ✓ |
| Shop Ancestry | Shop Premium | Shop Total Health | |
**The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of 44 variants in the BRCA1 and BRCA2 genes. The report describes if a person's genetic result is associated with an increased risk of developing breast cancer and ovarian cancer and may be associated with an increased risk for prostate cancer, pancreatic cancer, and potentially other cancers. The variants included in this report do not represent the majority of the BRCA1/BRCA2 variants in people of most ethnicities. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. This report is for over-the-counter use by adults over the age of 18, and provides genetic information to inform discussions with a healthcare professional. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/shop/test-info/
***23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetic reports, visit 23andme.com/shop/test-info/pharmacogenetics/

